ArticlePDF Available

Trichoscopy of Steroid-Induced Atrophy

Authors:

Abstract and Figures

Intralesional corticosteroid (IL-CS) injections have been used to treat a variety of dermatological and nondermatological diseases. Although an important therapeutic tool in dermatology, a number of local side effects, including skin atrophy, have been reported following IL-CS injections. We recently noticed that a subset of patients with steroid-induced atrophy presented with ivory-colored areas under trichoscopy. We performed a retrospective analysis of trichoscopic images and medical records from patients presenting ivory-colored areas associated with atrophic scalp lesions. In this paper, we associate this feature with the presence of steroid deposits in the dermis and report additional trichoscopic features of steroid-induced atrophy on the scalp, such as prominent blood vessels and visualization of hair bulbs.
This content is subject to copyright.
E-Mail karger@karger.com
Original Article
Skin Appendage Disord 2017;3:171–174
DOI: 10.1159/000471771
Trichoscopy of Steroid-Induced Atrophy
RodrigoPirmez a LeonardoS.Abraham b BrunaDuque-Estrada a
PatríciaDamasco b DéboraCadoreFarias c YannaKelly d IsabellaDoche d
a Department of Dermatology, Instituto de Dermatologia Professor Rubem David Azulay, Santa Casa da
Misericórdia do Rio de Janeiro, Rio de Janeiro ,
b Department of Dermatology, Hospital Regional da Asa Norte,
Brasília , c Department of Dermatology, Universidade Federal de Santa Catarina, Florianópolis , and
d Department
of Dermatology, Universidade de São Paulo, São Paulo , Brazil
Introduction
Intralesional corticosteroid (IL-CS) injections have
been used to treat a variety of dermatological and nonder-
matological diseases
[1] . IL-CS injections are, for exam-
ple, considered as a first-line therapy in patchy alopecia
areata
[2] . Although an important therapeutic tool in der-
matology, a number of local side effects, including skin
atrophy, have been reported following IL-CS injections
[1] . We recently noticed that a subset of patients with ste-
roid-induced atrophy presented with ivory-colored areas
under trichoscopy ( Fig.1 ). In this paper, we associate ivo-
ry-colored areas with the presence of steroid deposits in
the dermis and report additional trichoscopic features of
steroid-induced atrophy. To the best of our knowledge,
there are no other studies reporting such data.
Materials and Methods
We performed a retrospective analysis of trichoscopic images
and medical records from patients presenting ivory-colored areas
associated with atrophic scalp lesions. All patients had been seen
for different types of hair loss, including both scarring and non-
scarring alopecias, at 4 referral centers in Brazil. Diagnosis was
established clinically by dermatologists with experience in hair dis-
Keywords
Alopecia · Corticosteroid · Dermoscopy · Intralesional
injection · Skin atrophy · Steroids · Trichoscopy
Abstract
Intralesional corticosteroid (IL-CS) injections have been used
to treat a variety of dermatological and nondermatological
diseases. Although an important therapeutic tool in derma-
tology, a number of local side effects, including skin atrophy,
have been reported following IL-CS injections. We recently
noticed that a subset of patients with steroid-induced atro-
phy presented with ivory-colored areas under trichoscopy.
We performed a retrospective analysis of trichoscopic im-
ages and medical records from patients presenting ivory-
colored areas associated with atrophic scalp lesions. In this
paper, we associate this feature with the presence of steroid
deposits in the dermis and report additional trichoscopic
features of steroid-induced atrophy on the scalp, such as
prominent blood vessels and visualization of hair bulbs.
© 2017 S. Karger AG, Basel
Received: February 10, 2017
Accepted: March 15, 2017
Published online: April 28, 2017
Rodrigo Pirmez
Rua Visconde de Pirajá 330, salas 1001–1003
Rio de Janeiro, RJ 22410-000 (Brazil)
E-Mail rodrigopirmez @ gmail.com
© 2017 S. Karger AG, Basel
www.karger.com/sad
Pirmez/Abraham/Duque-Estrada/
Damasco/Farias/Kelly/Doche
Skin Appendage Disord 2017;3:171–174
DOI: 10.1159/000471771
172
orders and, in doubtful cases, was confirmed through pathology.
Clinical information is summarized in Table1 . Trichoscopy and
photographic documentation were performed using either Foto-
Finder Dermoscope
® , FotoFinder Handyscope
® (Teachscreen
Software, Bad Birnbach, Germany), or DermLite
® Foto (3Gen,
San Juan Capistrano, CA, USA) attached to a Nikon
® J1 camera.
Results
Twenty-five lesions from 8 patients were retrieved. All
patients had been submitted to IL-CS injections as part of
their treatment. In 3 patients, biopsies from ivory-colored
areas were available and revealed circumscribed, fine pale
foamy material in the dermis, suggestive of steroid depos-
its ( Fig.2 )
[3] .
Another remarkable trichoscopic feature was the pres-
ence of prominent blood vessels in 23 (92%) lesions
( Fig.3 ), which were classified as thin (16 lesions; 64%)
and thick arborizing (15 lesions; 60%) and which in 3 le-
sions (12%) were so numerous as to form a vascular net-
work. Visualization of hair bulbs through the atrophic
skin was evident in 5 lesions (20%) ( Fig.4 a). Interesting-
ly, in 5 (out of 12) lesions of patients with alopecia areata,
regrowing hairs were organized as a collar that surround-
ed the steroid deposits ( Fig.4 b).
During our research, another 8 patients with 13 similar
lesions in areas other than the scalp were also identified.
Such patients had also been submitted to IL-CS injections
for different reasons (clinical information can be found
in Table2 ).
Discussion
The presence of steroid deposits has already been re-
ported after triamcinolone injections in different body
areas, such as the vocal cords and eyes
[4, 5] . In our case
series, the reason for such deposits can only be specu-
lated on. However, it is remarkable that in 25 lesions (out
of 28 in which the steroid used is known) the corticoste-
roid injected was triamcinolone hexacetonide, which is
known to be much less soluble than other steroids, in-
cluding triamcinolone acetonide
[6, 7] . Some authors
have even considered triamcinolone hexacetonide to be
unsuitable for intralesional injection due to its inordi-
nately long half-life
[1] . Furthermore, in the 25 lesions in
which triamcinolone hexacetonide was used, concentra-
tions were equal to or higher than 10 mg/mL in 24 lesions
(96%), which could serve as an additional risk factor for
steroid deposition and tissue atrophy. Another interest-
ing point to consider is that triamcinolone hexacetonide
should not be mixed with diluents or local anesthetics
containing preservatives, such as parabens or phenols,
since they may cause precipitation of the steroid
[1] .
Even though this information was not available, we can-
not exclude that the type of diluent used may have played
a role in the formation of cutaneous deposits in some
cases.
Steroid-induced atrophy may be self-limited [8] . It is
unknown whether the presence of steroid deposits in the
dermis may hinder resolution of cutaneous atrophy. Ac-
Table 1. Clinical information from patients with scalp lesions of
steroid-induced atrophy presenting ivory-colored areas
Patient Gender Age,
years
Lesions,
n
Condition Corticosteroid
and concentra-
tion, mg/mL
1 f 30 7 AA TH 10
2 f 26 1 HS BD 5 + BDS 2
3 f 68 2 DLE TH 10
4 f 41 2 AA TA 10
5 m 28 2 AA TH 20
6 f 74 1 LPP TH 05
7 f 68 9 FFA unknown
8 f 59 1 AA unknown
AA, alopecia areata; HS, hypertrophic scar; DLE, discoid lupus
erythematosus; LPP, lichen planopilaris; FFA, frontal fibrosing
alopecia; TH, triamcinolone hexacetonide; BD, betamethasone
dipropionate; BDS, betamethasone disodium phosphate; TA,
triamcinolone acetonide.
Fig. 1. Ivory-colored areas seen under trichoscopy in an alopecia
areata patient presenting corticosteroid-induced skin atrophy.
Original magnification: ×20.
Color version available online
Trichoscopy of Steroid-Induced Atrophy Skin Appendage Disord 2017;3:171–174
DOI: 10.1159/000471771
173
Table 2. Clinical information from patients with body lesions of steroid-induced atrophy presenting ivory-
colored areas
Patient Gender Age,
years
Lesions,
n
Body location Condition Corticosteroid and
concentration, mg/mL
1 m 31 2 abdomen HS TH 20
2 f 32 2 face/chest acne cysts TH 20
3 f 70 2 arms granuloma annulare TH 20
4 f 34 1 inframammary HS TH 10
5 f 41 1 abdomen HS TH 20
6 f 35 2 abdomen/arm HS TH 20
7 f 32 2 breasts HS TH 20
8 m 32 1 chest HS TH 20
HS, hypertrophic scarring; TH, triamcinolone hexacetonide.
ab
abc
Fig. 2. Biopsies from ivory-colored areas revealed circumscribed, fine pale foamy material present in the dermis
(
a ), which can be better visualized in b . HE staining. Original magnification: a ×100 and b ×200.
Fig. 3. Vascular changes in steroid-induced atrophy. Trichoscopy showed thin arborizing vessels ( a ), thick arbo-
rizing vessels (
b ), and blood vessels forming a vascular network ( c ). For classification purposes, vessels thinner
than the average hair were considered as “thin” and vessels thicker than the average hair as “thick.” Original mag-
nification: ×20.
Color version available onlineColor version available online
Pirmez/Abraham/Duque-Estrada/
Damasco/Farias/Kelly/Doche
Skin Appendage Disord 2017;3:171–174
DOI: 10.1159/000471771
174
cording to personal observations (B.D.-E. and L.S.A.),
surgical removal of the deposits leads to partial regression
of dermal atrophy, but prospective studies are necessary
to confirm this information.
One limitation of the study was the limited access to
patient data, since most of the patients were originally
treated by other physicians. Information lacking includes
the total number of injections received by each patient
and the duration of atrophy.
In conclusion, we describe ivory-colored areas as a
novel trichoscopic feature representing steroid deposits
in the dermis and suggest that their presence may indicate
the etiology of skin atrophy in cases in which a previous
history of IL-CS injections is not clear. We further report
additional features of steroid-induced atrophy on the
scalp, such as prominent vessels and visualization of hair
bulbs. Finally, we suggest the use of triamcinolone ace-
tonide rather than of its less soluble salt hexacetonide for
intralesional injections and at lower concentrations, typ-
ically at 2.5 and 5 mg/mL for scalp lesions.
Statement of Ethics
All patients have given their consent for their details to be de-
scribed in this article.
Disclosure Statement
The authors have no conflicts of interest to disclose.
Funding Sources
There were no funding sources for this work.
ab
Fig. 4. Additional trichoscopic features included visualization of hair bulbs ( a ) and collars of regrowing hairs
around the ivory-colored areas (
b ). Original magnification: ×20.
References
1 Firooz A, Tehranchi-Nia Z, Ahmed AR: Ben-
efits and risks of intralesional corticosteroid
injection in the treatment of dermatological
diseases. Clin Exp Dermatol 1995;
20: 363–
370.
2 Alkhalifah A, Alsantali A, Wang E, McElwee
KJ, Shapiro J: Alopecia areata update: part II.
Treatment. J Am Acad Dermatol 2010;
62:
191–202.
3 Kaur S, Amanjeet, Thami GP, Mohan H: In-
tralesional steroid induced histological
changes in the skin. Indian J Dermatol Vene-
reol Leprol 2003;
69: 232–234.
4 Wang CT, Lai MS, Hsiao TY: Comprehensive
outcome researches of intralesional steroid
injection on benign vocal fold lesions. J Voice
2015;
29: 578–587.
5 Okka M, Bozkurt B, Kerimoglu H, et al: Con-
trol of steroid-induced glaucoma with surgi-
cal excision of sub-Tenon triamcinolone ace-
tonide deposits: a clinical and biochemical ap-
proach. Can J Ophthalmol 2010;
45: 621–626.
6 Garg N, Perry L, Deodhar A: Intra-articular
and soft tissue injections, a systematic review
of relative efficacy of various corticosteroids.
Clin Rheumatol 2014;
33: 1695–1706.
7 Porter D, Burton JL: A comparison of intra-
lesional triamcinolone hexacetonide and tri-
amcinolone acetonide in alopecia areata. Br J
Dermatol 1971;
85: 272–273.
8 Chang KH, Rojhirunsakool S, Goldberg LJ:
Treatment of severe alopecia areata with in-
tralesional steroid injections. J Drugs Derma-
tol 2009;
8: 909–912.
Color version available online
... Although TH is thought to have a better efficacy compared to TA, 8 it is a less soluble derivative of TA and lower doses should be used in order to avoid skin atrophy. 9 Limitations of this study include retrospective analysis, lack of a control group, and treatment modalities chosen according to availability in our Institution. ...
... Similarly to the intralesional use, TAc is recommended over TH for intramuscular use, due to the greater risk of developing atrophy and telangiectasias in the long term. 43 The authors suggest, as a second option, the substitution by the combination of betamethasone dipropionate 5 mg/mL (fast action) with disodium phosphate betamethasone 2 mg/mL (prolonged action). 18 Table 13 presents the dose equivalence of the different CTs. ...
Article
Full-text available
Background Alopecia areata is a highly frequent disease with a great impact on quality of life and several treatment options with little clinical confirmatory evidence. Objective To disseminate the recommendations of Brazilian dermatologists with experience in the treatment of alopecia areata. Methods Eight specialists with experience in alopecia areata from different university centers were appointed by the Brazilian Society of Dermatology to reach a consensus on its treatment. Based on the adapted DELPHI methodology, the relevant elements were considered; then, an analysis of recent literature was carried out and the consensus was written down. Consensus on the management of alopecia areata was defined with the approval of at least 70% of the panel. Results/Conclusions Intralesional injectable corticotherapy was considered the first option for localized disease in adults. In extensive cases with signs of activity, systemic corticosteroid therapy should be considered and can be used together with immunosuppressants (corticosteroid-sparing). The use of an immunosensitizer (diphencyprone) is an option for stable long-term cases. Evaluation of side effects is as important as the rate of hair regrowth.
... Thick arborizing vessels, for example, are typically present in connective tissue diseases such as DLE and dermatomyositis 20 or as a side-effect in areas of steroid-induced atrophy. 21 ...
Article
Although trichoscopy has only recently been introduced in the assessment of hair and scalp disorders, it is already considered an essential diagnostic tool by many experts in the field. This article discusses topics that are often a source of doubt among clinicians, and tips that may help dermatologists better perform trichoscopy. Subjects include fundamental concepts needed to start performing the method, basic trichoscopic structures, tips to identify a scarring condition and to approach a patient with a receding hairline, features that are unique to children, those that are typically seen in the dark scalp, and pitfalls of the technique.
Article
Full-text available
Intralesional steroid injection is a treatment method frequently used to resolve a large number of orthopedic, rheumatological, dermatological, and neurological disorders. Although this treatment is very effective, it is not without possible side effects, both systemic and local, among which we can mention pain, bleeding, ulceration, atrophy, pigmentary changes, calcification, secondary infections, formation of granulomas, allergic reactions and, in very rare cases, the development of linear atrophy, and hypopigmentation. Here, we present a case of frontal linear skin atrophy after intralesional steroid injection for the treatment of alopecia areata (AA) in a 29 year‐old patient, successfully treated with a hyaluronic acid filler.
Article
Background: Eyebrow loss (madarosis) is a frequent sign of frontal fibrosing alopecia (FFA) and it can be the first sign of the disease. Objective: To describe trichoscopic findings of FFA on the eyebrows. Methods: The analysis included 151 women with histologically proven diagnosis of FFA and eyebrow loss. Trichoscopy of the eyebrow area was performed using either Fotofinder videodermatoscope or handheld dermoscope DermLite® II pro. Results: The most frequent trichoscopic signs were yellow dots (92.7%), multiple pinpoint dots (79.5%), short thin hairs/vellus (76.2%), black dots (66.2%), and dystrophic hairs (60.9%). Tapering hairs were found in 21 (13.9%) and dystrophic hairs in 92 (60.9%) patients. Limitations: Inner limitations of a case series (there was no comparison to normal controls or individuals with other hair disorders) and lack of histological correlation to the trichoscopic findings. Conclusion: Although FFA is a scarring alopecia, the most common trichoscopic signs found in the eyebrows are usually related to non-cicatricial alopecia. Therefore, in most cases trichoscopy of eyebrows does not resemble the trichoscopy of FFA on scalp. Black dots, dystrophic hairs and broken hairs are frequent signs. Occasionally tapered hairs can be present on eyebrows of FFA leading to misdiagnosis of AA.
Chapter
Intralesional steroid (IL-S) injections have been used to treat a variety of dermatological and nondermatological diseases. In the treatment of alopecias, IL-S are an important therapeutic tool for many types of both scarring and nonscarring hair loss. This chapter covers practical topics such as the type and concentration of the steroid to be injected, indications, technique of injection, potential local and systemic adverse effects, and how to prevent them.
Article
Background/Objectives Videodermoscopy is a valuable tool for the diagnosis of cicatricial alopecias such as lichen planopilaris. Lichen planopilaris activity index is used for evaluating lichen planopilaris severity. Our aim was to examine the utility of videodermoscopy in the assessment of lichen planopilaris severity. Methods One hundred and seventeen histopathologically confirmed lichen planopilaris patients under went videodermoscopy. Lichen planopilaris activity index was calculated according to cicatricial alopecia standardised flowchart. Differences and correlations between trichoscopic features, clinical findings and lichen planopilaris activity index were calculated. Results Most trichoscopic features had statistically significant higher prevalence than similar clinical findings. Targetoid pigment pattern, perifollicular scale and milky‐red areas were significantly correlated with lichen planopilaris activity index (P‐value < 0.05). There was statistically significant correlation between targetoid pigment pattern and positive anagen pull test (P‐value < 0.001). Conclusion Using trichoscopic features in calculating lichen planopilaris activity index with videodermoscope can help in early lichen planopilaris diagnosis and improve post‐treatment follow‐up.
Article
Full-text available
To assess the efficacy of surgical excision of sub-Tenon triamcinolone acetonide (TA) deposits in the control of steroid-induced glaucoma. Prospective, nonrandomized, interventional case series. Eighteen eyes of 14 subjects with increased IOP within 6 months of sub-Tenon TA injection who did not respond to medical antiglaucomatous treatment were included in the study. Under topical anaesthesia, steroid deposits were completely excised and placed in ethyl alcohol for the determination of the TA amount using high-performance liquid chromatography. The patients were followed up for 6 months and a paired-sample t test was used to compare mean IOP before and after excision of sub-Tenon TA deposits. The mean IOP levels before and after the sub-Tenon steroid injections were 15.9 (SD 2.9) mm Hg and 36.4 (SD 8.4) mm Hg, respectively (p < 0.001). IOP levels decreased significantly after the removal of the deposits (mean 15.3 [SD 2.1] mm Hg) (p < 0.001). Within 6 months of follow-up, all glaucoma medications were stopped in 9 subjects without further IOP increase, whereas IOP control in 5 subjects necessitated using glaucoma medications. The median TA amount was found to be 7.35 mg (range 3.3-29.68 mg). IOP decrease after the excision showed no correlation with the amount of TA (p = 0.8). Surgical excision of the sub-Tenon steroid deposit should be considered as the primary treatment for steroid-induced glaucoma refractory to medical treatment.
Article
Full-text available
Unlabelled: Various therapeutic agents have been described for the treatment of alopecia areata (AA), but none are curative or preventive. The aim of AA treatment is to suppress the activity of the disease. The high rate of spontaneous remission and the paucity of randomized, double-blind, placebo-controlled studies make the evidence-based assessment of these therapies difficult. The second part of this two-part series on AA discusses treatment options in detail and suggests treatment plans according to specific disease presentation. It also reviews recently reported experimental treatment options and potential directions for future disease management. Learning objectives: After completing this learning activity, participants should be able to compare the efficacy and safety of various treatment options, formulate a treatment plan tailored to individual patients, and recognize recently described treatments and potential therapeutic approaches.
Article
This study investigated multidimensional treatment outcomes, including prognostic factors and side effects of vocal fold steroid injection (VFSI). We recruited 126 consecutive patients, including patients with 49 nodules, 47 polyps, and 30 mucus retention cysts. All the patients received VFSI under local anesthesia in the office settings. Treatment outcomes were evaluated 1 and 2 months after the procedure, including endoscopic evaluation, perceptual voice quality (GRB scores), acoustic analysis, and 10-item Voice Handicap Index (VHI-10). More than 80% of the patients reported subjective improvements after VFSI. Objective measurements revealed significant improvements from baseline in most of the outcome parameters (P<0.05). Higher occupational vocal demands and fibrotic vocal nodules were significantly associated with poorer clinical responses as measured by the VHI-10 and GRB scores, respectively. For vocal polyps, dysphonia for more than 12 months were significantly associated with higher postoperative VHI-10 scores, whereas patients with laryngopharyngeal reflux (LPR) showed significantly poor postoperative voice quality as measured by GRB scores. Side effects after VFSI included hematoma (27%), triamcinolone deposits (4%), and vocal atrophy (1%), which resolved spontaneously within 1-2 months. Presentation with vocal fold ectasias/varicosities and higher vocal demands were significantly correlated with postoperative vocal hematoma. This study demonstrated significant improvements after VFSI in vocal nodules, polyps, and cysts. Occupational vocal demand and subtypes of vocal nodules are closely related to the treatment outcomes after VFSI, whereas symptom duration and LPR were significant prognostic factors for VFSI treatment outcomes in vocal polyps. Side effects after receiving VFSI were mostly self-limited without sequel, whereas the incidence rates might be varied by the injection approach and the timing for postoperative follow-up. Copyright © 2015 The Voice Foundation. Published by Elsevier Inc. All rights reserved.
Article
The comparative efficacy of various Corticosteroid (CS) injections commonly used to treat musculoskeletal conditions has not been systematically studied. Our objective is to synthesize data about comparative efficacy of various CS used for intra-articular and periarticular soft tissue injections. Online databases were searched including MEDLINE, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effectiveness, and bibliographies of studies till November 2013. We included all randomized controlled trials comparing two CS for intra-articular and periarticular injections, selected according to Preferred Reporting Items for Systematic reviews and Meta-Analyses methodology. Seven good quality trials were selected for qualitative data synthesis. Two trials comparing triamcinolone hexacetonide (TH) and methylprednisolone (MP) for knee arthritis suggested faster pain relief with TH for rheumatoid arthritis (RA) at day 7 (p < 0.05) and osteoarthritis (OA) at week 3 (visual analogue scale, 33 mm vs 14 mm, p < 0.01) but a similar long-term efficacy. One trial suggested faster pain relief with MP compared to triamcinolone acetonide (TA) for rotator cuff tendonitis at 2 weeks (percentage of patients improving 92 % vs. 50 %; p = 0.02) but similar long-term efficacy, while another trial suggested no difference between TA and MP for knee OA. Two trials for knee arthritis suggested a substantially better efficacy for TH than TA (response rate at 24 months 77 % vs 39 %; p = 0.001) and betamethasone (BM) at day 42 (p < 0.01). There is paucity of data regarding comparative efficacy of various CS injections. Limited number of studies favored TH over other CS (TA, MP, BM).
Article
— A comparison of the effects of intralesional triamcinolone acetonide and its less soluble derivative triamcinolone hexacetonide in alopecia areata has shown that both steroids produce a constant linear rate of growth of hair tuft, and the effect of a single injection can persist for at least 9 months.
Article
Treatment of alopecia areata with intralesional steroid injection is generally recommended for people who have less than 50% scalp involvement. In a specialized hair loss clinic, the authors successfully treated patients with extensive alopecia areata (over 50% but under 99%) with intralesional corticosteroid injections. A review of patients with extensive alopecia areata was done. Six out of 10 patients responded to treatment with intralesional triamcinolone acetonide. In comparison to the non-responders, the responders tended to have exclamation mark hairs and a positive hair pull test at their initial physical examination, and exhibited improvement during the initial months of treatment. Complications were negligible, with mild reversible atrophy in three patients. The treatment was well tolerated and, in some patients, pain was minimized by use of a topical anesthetic agent applied under occlusion prior to the visit. Intralesional triamcinolone acetonide is a safe and effective treatment for patients with extensive alopecia areata. Patients with exclamation point hairs and a positive hair pull test may be more likely to respond.
Article
Intralesional corticosteroid (CS) injections have been used to treat a variety of dermatological and non-dermatological diseases with variable results. The purpose of the injection is to attain a high concentration of the drug at the diseased site, with minimal systemic absorption. Several CS preparations are available for intralesional injection, although triamcinolone derivatives have gained the widest usage in dermatology. The dose and the interval between injections depend on the type, size and severity of the lesion as well as the response to the previous injections. The most critical issue in the efficacy and also in the development of complications of the injections, is the method of injection. Several local and systemic side-effects have been reported following intralesional injections, but most of them are rare or acceptable. Thus intralesional CS injection is an integral part of the clinical practice of dermatology. Since their introduction in 1951,1 intralesional CS injections have become an integral part of clinical practice in dermatology. They are used alone or in combination with other therapeutic modalities in the treatment of many skin diseases. The purpose of the injection is to attain a high local concentration of the CS at the diseased site, without significant systemic absorption, thus avoiding the numerous side-effects associated with systemic administration. Intralesional CS injection may he a valuable therapeutic modality in situations where topical CS are not suitable for use, either because of low potency and inefficient epidermal harrier penetration or in clinical conditions associated with epidermal atrophy.
Article
Intralesional steroids are commonly used in dermatology. Besides their strong anti-inflammatory effects, the long acting steroids and other preservative agents may induce interesting histopathological changes, which may simulate focal mucinosis or a granulomatous pathology. A variety of histopathological changes induced by Intralesional injection of steroid in a lesion of keloid are being described.